Systemic Sclerosis: Clinical Trials

12 trials for Systemic Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 not yet recruiting, 3 recruiting, 2 completed, 2 unknown. 12 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 112Not yet recruiting 4, Recruiting 3, Completed 2, Unknown 2, Suspended 1

Follow Systemic Sclerosis: new trials by email Literature Review of Systemic Sclerosis trials Research Report on Systemic Sclerosis

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial
Hyaluronidase (Hylenex) - Systemic Sclerosis, Sclerodactyly
Early Phase 1Not yet recruitingMedical University of South Carolina102026-11-012026-10-16
CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases
RD06-05 CAR-T Cell Injection - SLE - Systemic Lupus Erythematosus, Systemic Sclerosis
Early Phase 1Not yet recruitingNanjing Bioheng Biotech Co., Ltd.302026-09-012026-07-16
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
anti-CD19/BCMA U CAR T cells - Autoimmune Diseases, Systemic Lupus Erythematosus
Early Phase 1RecruitingChanghai Hospital602026-02-202026-02-25
Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
UTAA91 injection - Systemic Lupus Erythematosus, Rheumatoid Arthritis
Early Phase 1Not yet recruitingPersonGen BioTherapeutics (Suzhou) Co., Ltd.152025-05-182025-05-14
Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
RD06-05 CART Cell Injection - SLE, Systemic Sclerosis
Early Phase 1RecruitingNanjing Bioheng Biotech Co., Ltd.182025-01-032026-02-02
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
CD19 or CD19-BCMA CAR-T - SLE (Systemic Lupus), Systemic Sclerosis
Early Phase 1RecruitingNanjing Bioheng Biotech Co., Ltd.202024-09-142026-03-06
Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases
RD06-04 CART Cell Injection - Systemic Lupus Erythematosus, Systemic Sclerosis
Early Phase 1SuspendedNanjing Bioheng Biotech Co., Ltd.122024-09-132026-02-03
The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases
anti-CD19-CAR-T cells - Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome
Early Phase 1Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University92024-05-272024-05-17
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
T cell injection targeting CD19 chimeric antigen receptor - Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies
Early Phase 1UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.102024-05-142024-05-16
Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients
SVF injection - Systemic Sclerosis
Early Phase 1CompletedSuk-Ho Moon202018-07-012020-10-08
The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )
Methylprednisolone, sodium chloride - Systemic Sclerosis, Raynaud Phenomena
Early Phase 1UnknownRadboud University Medical Center302017-01-012019-11-29
Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc)
buspirone - Systemic Sclerosis
Early Phase 1CompletedLaikο General Hospital, Athens222014-12-012016-10-24

Narrower conditions

Scleroderma, Systemic (12)  ·  Lupus Erythematosus, Systemic (7)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (6)  ·  Myositis (6)  ·  Autoimmune Diseases (5)  ·  Sjogren's Syndrome (5)  ·  Arthritis, Rheumatoid (3)  ·  Antiphospholipid Syndrome (1)  ·  Liver Cirrhosis, Biliary (1)  ·  Purpura, Thrombocytopenic, Idiopathic (1)

Broader conditions

Connective Tissue Diseases (12)  ·  Skin Diseases (12)  ·  Skin and Connective Tissue Diseases (12)  ·  Immune System Diseases (9)  ·  Arthritis (7)  ·  Joint Diseases (7)  ·  Musculoskeletal Diseases (7)  ·  Rheumatic Diseases (7)  ·  Cardiovascular Diseases (6)  ·  Muscular Diseases (6)  ·  Nervous System Diseases (6)  ·  Neuromuscular Diseases (6)  ·  Skin Diseases, Vascular (6)  ·  Systemic Vasculitis (6)  ·  Vascular Diseases (6)

Interventions

Antigens, CD19 (1)  ·  Buspirone (1)  ·  Hyaluronoglucosaminidase (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Sodium Chloride (1)

Sponsors

Nanjing Bioheng Biotech Co., Ltd. (4)  ·  PersonGen BioTherapeutics (Suzhou) Co., Ltd. (2)  ·  Changhai Hospital (1)  ·  First Affiliated Hospital of Wenzhou Medical University (1)  ·  Laikο General Hospital, Athens (1)  ·  Medical University of South Carolina (1)  ·  Radboud University Medical Center (1)  ·  Suk-Ho Moon (1)

Countries

China (7)  ·  Greece (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Georgios Karamanolis (1)  ·  Jian Wu, Doctor (1)  ·  LI Sun, Master's (1)  ·  Madelon Vonk, Dr. (1)  ·  Qiong Fu, Doctor (1)  ·  Seung-Ki Kwok (1)  ·  Suk-Ho Moon, MD, PhD (1)

Results publications

PMID 27586891, PMID 30134971, PMID 32961802, PMID 38552324